Clinical Trials
99
Trial Phases
5 Phases
Drug Approvals
42
Drug Approvals
Iodinated Oil Injection
- Product Name
- Lipiodol Ultra Fluide
- Approval Number
- 国药准字HJ20171362
- Approval Date
- Nov 16, 2022
Gadoteric Acid Meglumine Salt Injection
- Product Name
- 多它灵
- Approval Number
- 国药准字HJ20160126
- Approval Date
- Feb 10, 2021
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
Distribution across different clinical trial phases (70 trials with phase data)• Click on a phase to view related trials
Performance of Elucirem® in DSC-MRI Perfusion of Brain Gliomas
- Conditions
- Brain Tumor, RecurrentBrain Tumor, Primary
- Interventions
- First Posted Date
- 2023-09-28
- Last Posted Date
- 2025-05-06
- Lead Sponsor
- Guerbet
- Target Recruit Count
- 138
- Registration Number
- NCT06057168
- Locations
- 🇭🇺
Országos Idegtudományi Intézet - Neuroonkológiai és Intracraniá, Budapest, Hungary
🇭🇺Semmelweis Egyetem - Neurologiai Klinika, Budapest, Hungary
🇭🇺Debreceni Egyetem, Debrecen, Hungary
Evaluation of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and Children
- Conditions
- Lesion in Body RegionCNS Lesion
- Interventions
- Drug: Comparator
- First Posted Date
- 2023-08-24
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Guerbet
- Target Recruit Count
- 240
- Registration Number
- NCT06010173
- Locations
- 🇯🇵
Meitetsu Hospital, Aichi, Japan
🇯🇵Fukuoka University Hospital, Fukuoka, Japan
🇯🇵Gifu University Hospital, Gifu, Japan
Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of Age
- Conditions
- Central Nervous System DiseasesPediatric DisorderBody Indication
- Interventions
- First Posted Date
- 2022-10-21
- Last Posted Date
- 2025-03-28
- Lead Sponsor
- Guerbet
- Target Recruit Count
- 36
- Registration Number
- NCT05590884
- Locations
- 🇺🇸
Cincinnatti Childrens Hospital, Cincinnati, Ohio, United States
🇺🇸Medical University of South Carolina, Charleston, South Carolina, United States
🇭🇺Semmelweis Egyetem, Budapest, Hungary
Safety and Performance of Optivantage Multi-use When Injecting Contrast Media for Contrast Enhanced CT Examination
- Conditions
- Patient Participation
- First Posted Date
- 2022-09-13
- Last Posted Date
- 2022-09-13
- Lead Sponsor
- Guerbet
- Target Recruit Count
- 100
- Registration Number
- NCT05537779
Safety and Performance of Vectorio® in Conventional Trans-Arterial Chemo-Embolization (cTACE): A Post-Market Clinical Follow-up
- Conditions
- Oncology
- First Posted Date
- 2022-04-07
- Last Posted Date
- 2022-09-15
- Lead Sponsor
- Guerbet
- Target Recruit Count
- 50
- Registration Number
- NCT05316077
- Locations
- 🇦🇹
Univ.-Klinik für Radiologie, Graz, Austria
🇫🇷CHU-Hôpital François Mitterrand, Dijon, France
🇨🇭CHUV, Lausanne, Switzerland
- Prev
- 1
- 2
- 3
- 4
- 5
- 9
- Next
News
NUCLIDIUM's Copper-Based Radiotracer Shows Enhanced Imaging Performance in First Prostate Cancer Patient
NUCLIDIUM's 61Cu-NODAGA-PSMA I&T radiotracer successfully imaged the first patient in a phase 1 trial, showing more osseous lesions than FDA-approved 18F-piflufolastat at 1 hour post-injection.